HC Wainwright Forecasts Weaker Earnings for Legend Biotech
Legend Biotech Co. (NASDAQ:LEGN – Free Report) – Equities researchers at HC Wainwright lowered their Q4 2025 earnings per share estimates for shares of Legend Biotech in a research report issued on Wednesday, March 12th. HC Wainwright analyst M. Kapoor now forecasts that the company will earn $0.11 per share for the quarter, down from […]
